Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-002459
Filing Date
2025-07-24
Accepted
2025-07-24 14:38:28
Documents
6
Period of Report
2025-07-24

Document Format Files

Seq Description Document Type Size
1 6-K zk2533478.htm 6-K 13352
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 23657
3 image00001.jpg GRAPHIC 92505
4 image00004.jpg GRAPHIC 23209
5 image00005.jpg GRAPHIC 19668
6 image00006.jpg GRAPHIC 17602
  Complete submission text file 0001178913-25-002459.txt   249280
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-22320 | Film No.: 251146473
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)